Citadel Advisors - ONCTERNAL THERAPEUTICS INC ownership

ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 57 filers reported holding ONCTERNAL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ONCTERNAL THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,692
-63.9%
10,700
-17.8%
0.00%
Q1 2023$10,215
-43.0%
13,013
-27.3%
0.00%
Q4 2022$17,911
+49.3%
17,911
+29.8%
0.00%
Q3 2022$12,000
-99.1%
13,800
-98.8%
0.00%
Q2 2022$1,323,000
+326.8%
1,191,453
+433.1%
0.00%
Q1 2022$310,000
-1.0%
223,498
+62.3%
0.00%
Q4 2021$313,000
-70.9%
137,684
-46.5%
0.00%
Q3 2021$1,074,000
-3.8%
257,551
+9.6%
0.00%
Q2 2021$1,116,000
-57.4%
234,919
-25.3%
0.00%
Q1 2021$2,617,000
+1448.5%
314,578
+814.5%
0.00%
Q4 2020$169,00034,4000.00%
Other shareholders
ONCTERNAL THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 360,000$1,710,0000.88%
APIS CAPITAL ADVISORS, LLC 120,000$570,0000.49%
Parkman Healthcare Partners LLC 415,384$1,973,0000.43%
Altium Capital Management LP 172,218$818,0000.19%
Vigilare Wealth Management 52,535$250,0000.15%
BRIGHTON JONES LLC 332,875$1,581,0000.08%
Ikarian Capital, LLC 200,204$950,0000.08%
IPG Investment Advisors LLC 31,106$147,754,0000.04%
DOWLING & YAHNKE LLC 150,464$715,0000.04%
Jump Financial, LLC 58,225$276,0000.03%
View complete list of ONCTERNAL THERAPEUTICS INC shareholders